Overcoming 5 Common Barriers to Harmonised Real World Data

53:28

Effective Ingestion and Normalisation of Real World Data Sources

50:02

Engagement and Retention of Patients in Clinical Trials

44:46

Applying the Latest Digital Technology Trends to Patient, Provider and Payer Communications

This webinar reviews current trends and how digital technology and innovation are being applied to patient, healthcare professional, payer, and other decision maker communications.

51:01

Industry Perceptions and Expectations_ The Role of ICER as an Independent HTA

This webinar explores: the evolution of health technology assessment in the US and possibilities for the future; opinions of manufacturers and US payer stakeholders on the role of ICER in the US healthcare system; ICER methodologies and approaches

1:02:20

What is next in eCOA

In this webinar, we review the accumulating evidence to support measurement equivalence of instruments when migrated to ePRO. We review meta analyses of published quantitative equivalence studies, and a newly published meta synthesis of unpublished c

48:36

Industry Analysis_ Impact of FDA’s Recent Guidance on Payer Communications

Our experts explore how manufacturers can successfully implement the FDA's guidance on Payer Communications and integrate these new communication channels with payers

57:23

Bring your own device (BYOD) eCOA – Instrument Validation Methodology

This webinar discusses how we can develop a methodology and minimum standards for migrating instruments that would be applicable to any device.

1:02:33

Market Access Hurdles for Cell and Gene Therapies: Managing Evidence to Enhance Market Adoption

The emergence and rise of gene and cell therapies has the potential to significantly change the way we manage and treat disease. While payers recognize that gene and cell therapies are likely to be the next big step in the evolution of medicine, the

31:44

Evolving Best Practices for Working with Authors – Authorship and Beyond

Our experts discuss examine good publication practices that will help to streamline your interactions with scientific authors, while enhancing the quality, efficiency and effectiveness of your industry sponsored research projects.

31:32

Outcomes-Based Agreements and Innovative Contracting for Biopharmaceutical

Learn why traditional contracting may not be enough to address the needs of both payers and pharma manufacturers

58:48

Optimise your Regulatory & HTA Submissions with a Comprehensive Health Economic & Epidemiologic Evidence Strategy

Learn how having a comprehensive health economic and epidemiologic evidence strategy and evidence generation plan can optimise your regulatory and HTA submissions.

52:00